Allergy and Immunology · Charleston, SC
NPI
1003044645
Since 2009
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
4,590 services
Medicare patients, 2024
305
Average age 72
Drug cost, 2024
$96K
627 prescriptions
Company payments, 2025
$1,411
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carolyn R Word was code J2357 (injection, omalizumab, 5 mg), 1,486 times for 12 patients. In total Carolyn R Word billed 4,590 services in 24 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2357 Injection, omalizumab, 5 mg | Office | 1,486 | 12 | $30.13 | $45K |
| 95004 Test - Miscellaneous | Office | 730 | 14 | $2.61 | $1,906 |
| 95117 Treatment - Miscellaneous | Office | 309 | 148 | $8.07 | $2,494 |
| 95165 Treatment - Miscellaneous | Office | 265 | 12 | $9.95 | $2,638 |
| 99214 Office E&M - Established | Office | 93 | 58 | $90.70 | $8,436 |
| 95115 Treatment - Miscellaneous | Office | 81 | 37 | $6.47 | $524 |
| 96372 Injection Administration | Office | 79 | 23 | $10.29 | $813 |
| 94010 Pulmonary Function Testing | Office | 61 | 41 | $18.21 | $1,111 |
| 99213 Office E&M - Established | Office | 55 | 46 | $64.39 | $3,542 |
| 99204 Office E&M - New | Office | 15 | 15 | $124.64 | $1,870 |
| 99211 Office E&M - Established | Office | 14 | 13 | $15.29 | $214 |
| 99203 Office E&M - New | Office | 12 | 12 | $82.82 | $994 |
| 96160 E&M - Miscellaneous | Office | 12 | 12 | $1.96 | $23.49 |
By year: 2022 $82K for 3,404 services; 2023 $88K for 4,498 services; 2024 $113K for 4,590 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carolyn R Word prescribed most often to Medicare patients was Montelukast Sodium, with 73 prescriptions and refills. In total Carolyn R Word wrote 627 Medicare prescriptions that cost $96K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 73 | 185 | 26 | $784 |
| Levocetirizine Dihydrochloride Generic | 67 | 146 | 19 | $872 |
| Breo Ellipta Fluticasone/Vilanterol | 41 | 67 | 11 | $25K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 35 | 36 | 19 | $879 |
| Azelastine Hcl Generic | 28 | 50 | 11 | $1,195 |
| Ipratropium Bromide Generic | 25 | 35 | 15 | $583 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 21 | 31 | Under 11 | $18K |
| Fluticasone Propionate Generic | 21 | 40 | 11 | $267 |
| Hydroxyzine Hcl Generic | 21 | 25 | Under 11 | $343 |
| Azelastine-Fluticasone Azelastine/Fluticasone | 20 | 28 | Under 11 | $2,732 |
| Famotidine Generic | 18 | 30 | Under 11 | $154 |
| Prednisone Generic | 17 | 17 | 15 | $23.88 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 15 | 17 | Under 11 | $2,348 |
| Azithromycin Generic | 13 | 13 | 13 | $49.08 |
| Bepotastine Besilate Generic | 13 | 17 | Under 11 | $2,037 |
Brand drugs: 207 claims; generic drugs: 420 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carolyn R Word $1,411 ($1,411 in general payments such as food, travel and fees) from 17 companies. The largest payer was Genzyme Corporation with $368.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 10 | $368 |
| AstraZeneca Pharmaceuticals LP AZN | 14 | $313 |
| Genentech USA, Inc. ROG.SW | 4 | $74.5 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $72 |
| Grifols USA, LLC | 2 | $69.04 |
| Amgen Inc. AMGN | 3 | $68.79 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $66.46 |
| Pfizer Inc. PFE | 3 | $64.35 |
| Pharming Healthcare, Inc. | 3 | $59.96 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $58.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.